NCT04508556View on ClinicalTrials.gov

Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

December 19, 2020

Study Completion Date

December 19, 2020

Conditions
Covid19
Interventions
DEVICE

Breath Biopsy face masks with removable filters and fitted PVA strip

Device developed for collection of breath samples

DIAGNOSTIC_TEST

Nasopharyngeal swab

Is a method for collecting a clinical test sample of nasal secretions from the back of the nose and throat.

DIAGNOSTIC_TEST

oropharyngeal swabs

Is a method for collecting a clinical test sample from the back of the throat.

Trial Locations (1)

1091

OLVG, Amsterdam

Sponsors

Lead Sponsor

Owlstone Ltd
All Listed Sponsors
collaborator

OLVG

NETWORK

collaborator

Maastricht University

OTHER

lead

Owlstone Ltd

INDUSTRY

NCT04508556 - Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study | Biotech Hunter | Biotech Hunter